Project Details
Description
PROJECT NARRATIVE
Heart failure with preserved ejection fraction (HFpEF) disproportionately afflicts older Black and Hispanic
Americans for which there are no effective medical therapies. Cardiac amyloidosis is a cause of heart failure
that we hypothesize is misdiagnosed in 10-15% of elderly patients, potentially comprising up to 500,000
people in the United States. In this application, we propose to recruit a cohort of elderly Black and Hispanic
patients with heart failure to define the number of patients who have cardiac amyloidosis by utilizing highly
sensitive heart imaging and blood tests that we have developed, and to explore differences in genetics and
sex as they relate to heart failure disease progression in cardiac amyloidosis.
Status | Finished |
---|---|
Effective start/end date | 5/1/19 → 2/28/23 |
Funding
- National Heart, Lung, and Blood Institute: US$1,317,084.00
- National Heart, Lung, and Blood Institute: US$176,033.00
- National Heart, Lung, and Blood Institute: US$1,429,986.00
ASJC Scopus Subject Areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.